Correlation Between Virax Biolabs and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Viridian Therapeutics, you can compare the effects of market volatilities on Virax Biolabs and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Viridian Therapeutics.
Diversification Opportunities for Virax Biolabs and Viridian Therapeutics
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Virax and Viridian is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Virax Biolabs and Viridian Therapeutics
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 1.7 times more return on investment than Viridian Therapeutics. However, Virax Biolabs is 1.7 times more volatile than Viridian Therapeutics. It trades about -0.04 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 221.00 in Virax Biolabs Group on August 27, 2024 and sell it today you would lose (20.00) from holding Virax Biolabs Group or give up 9.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Viridian Therapeutics
Performance |
| Timeline |
| Virax Biolabs Group |
| Viridian Therapeutics |
Virax Biolabs and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Viridian Therapeutics
The main advantage of trading using opposite Virax Biolabs and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |